Expecting more out of medicine

We are a clinical-stage biopharmaceutical company combining innovative chemistry with well-validated biology to make medicines more accessible for people living with chronic autoimmune and inflammatory diseases.

Arrow

We are led by an exceptional team of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization.

06

Venkat Thalladi, Ph.D.

Senior Vice President, Chemistry, Manufacturing & Controls
Read Bio
07

Paul Fatheree

Senior Vice President, Medicinal Chemistry
Read Bio
08

Richard H. Scheller, Ph.D. 

Chairman of the Board
Read Bio
09

Shaan C. Gandhi, M.D., D.Phil.

Director, Northpond Ventures
Read Bio
010

Jim Scopa, J.D. 

Biotechnology Investor and Director
Read Bio
011

Jake Simson, Ph.D.

Partner, RA Capital Management
Read Bio
012

Sharon Tetlow

Managing Partner, Potrero Hill Advisors
Read Bio
013

Lisa Bowers, M.H.S.A.

Chief Commercial Officer, Day One Biopharmaceuticals
Read Bio
014

Mittie Doyle, M.D., FACR

Chief Medical Officer, Aro Biotherapeutics
Read Bio
015

J. Kevin Judice, Ph.D.

Co-Founder & Chief Executive Officer
Read Bio
01

Richard H. Scheller, Ph.D. 

Chairman of the Board
Read Bio